Retail Trade and Distribution

• General Administration Department of the National Medical Products Administration, Implementing Measures for the Protection of Pharmaceutical Trial Data (Trial Implementation, Draft for Comments)

  国家药监局综合司药品试验数据保护实施办法 (试行，征求意见稿)

  China proposes different data protection periods for three categories of drugs / Issued: 2025-03-19

  April 17, 2025

• In the News: China Clarifies Data Export Rules; UK Foreign Influence; and Burberry Wins Trademark Case

  The Cyberspace Administration clarifies its approach to the export of personal and important information out of China; UK weighs whether to include China in foreign influence disclosure rules; and Burberry wins online trademark infringement suit.

  April 17, 2025

  

• In the News: China Restricts Outbound Investments; Shenzhen Foreign Hospitals; and US Companies Survey

  China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned hospitals following national legislation; and U.S. companies plan continuous engagement with China

  April 11, 2025

  

• State Council, Provisions for Implementation of the «Anti-Foreign Sanctions Law»

  国务院实施«中华人民共和国反外国制裁法»的规定

  China specifies penalties for a failure to implement sanction countering measures / CLP Reference: 1300/25.03.23 ; Promulgated: 2025-03-23 ; Effective: 2025-03-23

  April 08, 2025

• In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully Owns Its Chinese Operations

  China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.

  April 03, 2025

  

• Illumina’s Inclusion in China’s Unreliable Entity List: Patent Wars, Geopolitical Risks, and Compliance Strategies

  Jianwei (Jerry) Fang, Xiaoyu (Arthur) Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s Unreliable Entity List, as well as compliance recommendations for multinational corporations

  April 02, 2025

  

• In the News: Anti-Foreign Sanctions Law Expands; Chinese Companies Shift Manufacturing Overseas; and China Pushes for IP Protections Abroad

  China strengthens Anti-Foreign Sanctions Law in response to U.S. restrictions; Chinese firms move production facilities overseas amidst key economic changes; and China introduces regulations to protect interests in overseas IP disputes

  March 28, 2025

  

• In the News: AI Labeling Obligations; China's Second AI Copyright Ruling; and Prepaid Consumption

  Multinationals must comply with new Chinese labeling requirements while the U.S. and EU have other specifications; A second Chinese court ruling affirms AI-generated images have copyright protection; and Supreme People’s Court cracks down on fraudulent behavior of prepayment service providers

  March 20, 2025

  

• State Council, Regulations for the Administration of Video and Image Information Systems for Public Security

  国务院公共安全视频图像信息系统管理条例

  Hotel rooms and restaurants are prohibited from installing image capturing equipment / CLP Reference: 5600/25.01.13 ; Promulgated: 2025-01-13 ; Effective: 2025-04-01

  March 17, 2025

• Regulatory Developments in the China Pharmaceutical and Medtech Sector in 2024, and the Outlook for 2025

  Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications

  February 26, 2025